A recent study shows that the United States Food and Drug Administration (FDA) had received reports of at least 23 patients in the United States where diagnosed with esophageal cancer while on Fosamax. The time frame of these instances of esophageal cancer falls between the initial marketing of Fosamax in October 1995 all the way [...]